General Atlantic, L.P.
Source: SEC Form 13F · as of Mar 2026General Atlantic, L.P. holds 4 biotech & pharma companies tracked by BioSniper, totaling $413.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
4
Total value held
$413.1M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Pharvaris N.V. (PHVS)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| PHVSPharvaris N.V. | 8,031,252 | $226.9M |
| RVMDREVOLUTION MEDICINES, INC. | 707,791 | $68.8M |
| NRIXNurix Therapeutics, Inc. | 4,101,865 | $63.6M |
| CNTACentessa Pharmaceuticals plc | 1,354,830 | $53.8M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.